Logo

American Heart Association

  2
  0


Final ID:

Leveraging GWAS to Identify Novel Drug Targets

  • Bouatia-naji, Nabila  ( PARCC- INSERM UMR970 , Paris , France )
  • Ganesh, Santhi  ( INTERNAL MEDICINE/DIV CARDIO MED , Ann Arbor , Michigan , United States )
  • Author Disclosures:
    Nabila Bouatia-Naji: DO NOT have relevant financial relationships | Santhi Ganesh: No Answer
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Cutting-Edge Genetic and Precision Therapies in Cardiovascular Disease

Sunday, 11/17/2024 , 03:30PM - 04:45PM

Cardiovascular Seminar

More abstracts on this topic:
Precision-Based Small Molecule Therapeutics

Ho Carolyn, Ahmad Ferhaan

Gene Therapy for Rare Cardiovascular Diseases

Mcnally Elizabeth, Bursac Nenad

More abstracts from these authors:
Genome wide association study meta-analysis of 19,487 individuals with mitral valve prolapse identifies 52 novel genomic regions and highlights pro-fibrosis genes

Small Aeron, Wells Quinn, Wilson Peter, Cho Kelly, Rader Daniel, Ganna Andrea, Helgadottir Anna, Holm Hilma, Stefansson Kari, Gudbjartsson Daniel, Vy Ha My, Berrandou Takiy-eddine, Rosenberg Michael, Milan David, Borger Michael, Dieterlen Maja-theresa, Kontorovich Amy, Engert Jamie, Thanassoulis George, Farber-eger Eric, Gignoux Christopher, Ellinor Patrick, Georges Adrien, Peloso Gina, Norris Russell, Yu Mengyao, Bouatia-naji Nabila, Natarajan Pradeep, Morningstar Jordan, Huff Matthew, Yang Ta-yu, Lee Jiwoo, Abner Erik, Bundgaard Henning

Vascular MAPK/ERK Activation in sFTL-1-Induced Preeclampsia In Vivo

Kumar Nitin, Hunker Kristina, Ganesh Santhi

You have to be authorized to contact abstract author. Please, Login
Not Available